Vaccines, blood, antisera, toxins and cultures in   Czechia

Exports In 2023, Czechia exported $516M in Vaccines, blood, antisera, toxins and cultures, making it the 25th largest exporter of Vaccines, blood, antisera, toxins and cultures in the world. At the same year, Vaccines, blood, antisera, toxins and cultures was the 74th most exported product in Czechia. The main destination of Vaccines, blood, antisera, toxins and cultures exports from Czechia are: Germany ($96.3M), Hungary ($65.9M), Austria ($63.5M), Slovakia ($50.6M), and Netherlands ($31.5M).

The fastest growing export markets for Vaccines, blood, antisera, toxins and cultures of Czechia between 2022 and 2023 were Hungary ($45.8M), Slovakia ($35.5M), and Germany ($23.5M).

Imports In 2023, Czechia imported $1.78B in Vaccines, blood, antisera, toxins and cultures, becoming the 24th largest importer of Vaccines, blood, antisera, toxins and cultures in the world. At the same year, Vaccines, blood, antisera, toxins and cultures was the 18th most imported product in Czechia. Czechia imports Vaccines, blood, antisera, toxins and cultures primarily from: Germany ($441M), Switzerland ($297M), Netherlands ($202M), United States ($170M), and Belgium ($147M).

The fastest growing import markets in Vaccines, blood, antisera, toxins and cultures for Czechia between 2022 and 2023 were Switzerland ($102M), Netherlands ($67.8M), and South Korea ($35.1M).